It also enhances endurance, boosts energy levels, and aids in muscle recovery after exercise
@Optum GLP-1s are leading toward a healthier weight curve, which is a game-changer for managing health effectively
In the Phase 2 obesity trial published in NEJM in 2023, retatrutide at the 12 mg weekly dose produced a mean placebo-adjusted body weight reduction of 22.1 percentage points (22.1% (24.2% arm) mean absolute reduction on the retatrutide arm) at 48 weeks (Jastreboff et al., NEJM, 2023)
Read the full announcement: To view or add a comment, sign in Weight-loss drugs like Ozempic may also curb drug and alcohol addiction A new study published in the Journal of the Endocrine Society suggests that GLP-1 receptor agonists (GLP-1RAs) the same class of drugs used in diabetes and obesity treatments such as Ozempic and Wegovy may also help reduce alcohol and drug use
Daily as part of a longevity and healthy aging routine
doi:10.1001/jama.2021.3224 17Zafer M, Tavaglione F, Romero-Gmez M, Loomba R